Quarterly report · Q2
6788.TEDINET S100S6VB
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥18.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥848m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥926m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥30.1bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥29.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.5bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥21.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥149m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥551m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥232m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥985m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥500m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥486m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥155.76 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.27 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥214.78 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.6 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥194m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥9.2bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥9.2bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 505
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from subsidy income2 ope cf | Prior1YTDDuration | － | JPY |
| Proceeds from subsidy income2 ope cf | CurrentYTDDuration | 1049000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -548000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -1640000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -118651000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -495857000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 1177509000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 1493735000 | JPY |
| Proceeds from redemption of securities inv cf | Prior1YTDDuration | 500000000 | JPY |
| Proceeds from redemption of securities inv cf | CurrentYTDDuration | － | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -16000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -99900000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 72327000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -128496000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -227074000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -50635000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -4876000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | -100000000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | 63482000 | JPY |
| Other net inv cf | Prior1YTDDuration | 10666000 | JPY |
| Other net inv cf | CurrentYTDDuration | 46690000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 231516000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -149350000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -7350000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -5436000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -459512000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -970623000 | JPY |
| Other net fin cf | Prior1YTDDuration | -14095000 | JPY |
| Other net fin cf | CurrentYTDDuration | -13927000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -486395000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -984550000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 91268000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 114152000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 1013899000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 473986000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 11878323000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 12795930000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 12892223000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 13269917000 | JPY |
| Sales commission sga | Prior1YTDDuration | 583096000 | JPY |
| Sales commission sga | CurrentYTDDuration | 682950000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 615457000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 690298000 | JPY |
| Provision for product warranties sga | Prior1YTDDuration | 23331000 | JPY |
| Provision for product warranties sga | CurrentYTDDuration | 35848000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |